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Abstract
Background: The  conventional  right  ventricular  (RV)  lead  position  in  cardiac 
resynchronization  therapy  pacemakers  (CRT-P)  is  the  RV apex (RV-A).  Little  is  known 
about electrophysiological stability and associated complications of pacing leads in RV high 
posterior septal (RV-HS) position in CRT-P.                                                      
Methods: Two hundred and thirty-five consecutive CRT-P patients were included from 1999-
2010. Pacing thresholds at 0.5ms and 2.5V, sensing electrograms and lead impedances were 
measured  at  implant  and  repeated  1,3,6,12,18  and  24  months  after  CRT-P. 
Electrophysiological  measurements  of  leads  located  in  RV-A and RV-HS were  analyzed 
retrospectively.  Bipolar  RV  leads  were  used,  including  high  impedance  leads,  passive 
fixation  and  active  fixation.                                                    
Results: RV pacing leads were implanted in RV-A (n=79) and RV-HS (n=156). Average RV 
pacing  thresholds  from  CRT  implant  procedure  to  24-month  follow-up  at  0.5ms  were 
0.77±0.69V in RV-A and 0.71±0.35V in RV-HS (P=0.31), and at 2.5V were 0.06±0.08ms in 
RV-A  and  0.07±0.05ms  in  RV-HS  (P=0.12).  Average  RV  electrogram  amplitudes  from 
baseline to 24 months after CRT were 15.3±6.9mV in RV-A and 12.1±6.0mV in RV-HS 
(P=0.55).  Average  RV  impedances  during  follow-up  were  850±286Ω  in  RV-A  and 
618±147Ω in RV-HS (P=0.57). Similar RV lead revisions between RV-A and RV-HS were 
observed after  2-year  follow-up (P=0.55).                                              
Conclusions: The RV-HS lead position demonstrated stable and acceptable long-term pacing 
and sensing function,  with rates  of complications  comparable to  conventional  RV-A lead 
position in CRT. The RV-HS lead position is feasible in CRT-P.                                               
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Introduction
            
Cardiac  resynchronization  therapy  (CRT)  is  the  recommended  treatment  in  symptomatic 
heart failure (HF) patients on optimal medical treatment with left ventricular (LV) systolic 
dysfunction and prolonged QRS duration.[1-3] The conventional right ventricular (RV) lead 
placement in CRT has been at the RV apex (RV-A).[4] Recent studies on the detrimental 
effects  of  RV-A  pacing  on  LV  function  in  treating  bradyarrhythmias  has  increased  the 
interest  in  alternate  RV  pacing  sites.[5-6]  The  electrophysiological  performance  and 
associated complications of selective site pacing in the interventricular  septum of the RV 
outflow tract (RVOT) and RV mid septum has been studied in patients with a bradycardia 
indication for permanent pacing.[7-8]  In CRT, several studies have demonstrated the long-
term  electrophysiological  stability  and  associated  complications  of  conventional  lead 
placement.[9-12] Alternate RV lead position in CRT has demonstrated similar hemodynamic 
effects as RV-A in previous studies.[13-16] However, there are few data concerning long-
term electrophysiological stability and associated complications in alternate RV pacing sites 
in  CRT.                                          
We hypothesized  that  a  RV high  posterior  septal  (RV-HS)  lead  position  in  CRT would 
provide similar long-term pacing and sensing stability as compared to the conventional RV-
A. Thus, the aim of this study was to compare the electrophysiological performance of RV-
HS lead position in CRT pacemakers (CRT-P) to previously implanted RV-A in a two-year 
follow-up. The challenges encountered with the RV-A and RV-HS lead implant procedure 
and  need  for  lead  revisions  during  the  first  two  years  were  investigated.  
Methods
Patient  Population                                                
In this study, 237 consecutive HF patients referred to CRT pacemaker (CRT-P) implantation 
were  included  between  1999  and  2010.  Inclusion  criteria  were  HF  patients  on  optimal 
medical  treatment  in  New  York  Heart  Association  (NYHA)  functional  class  III-IV,  LV 
ejection fraction (LVEF) ≤ 35%, LV end-diastolic diameter ≥ 5.5 cm and QRS duration ≥ 
120ms. The regional ethics committee approved this study, and the patients were included 
after  informed  consent.                                            
Study  Protocol                                                       
RV pacing thresholds at 0.5ms and 2.5V, respectively, sensing R-wave amplitudes and lead 
impedances  at  5.0V  pacing  were  measured  during  the  pacemaker  implantation.  All 
measurements  were  repeated  at  follow-up  1,  3,  6,  12,  18  and  24  months  after  CRT. 
Pacemaker testing was performed by using Medtronic CareLink® pacemaker programmer 
(Medtronic, Minneapolis, MN, USA). Patients in need of lead revisions re-started the same 
routine  follow-up  intervals.                                        
 
CRT  Implantation  Procedure                                       
A CRT pacing system was implanted under local anaesthesia with a transvenous introduction 
of the leads via the left cephalic or subclavian vein using different bipolar RV leads (Table 
1).  Two experienced implanters  (SF,TH) performed the CRT-P implant  procedures.  Both 
CRT implanters placed the RV leads in RV-A and RV-HS equally distributed. During the 
first six years of CRT implantation the conventional RV-A lead placement was used at our 
center. The RV-HS lead placement was selected in the majority of the patients from 2005 
although the choice of lead position was left to the discretion of the implanting physician. 
The RV lead positions were achieved guided by fluoroscopy using three standard views as a 
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routine: anteriorposterior view (AP), left anterior oblique 30º view (LAO) and right anterior 
oblique 30º view (RAO). The RV-A lead position was defined as the distal part of RV lead 
close to or below the silhouette of left diaphragm visualized in the AP fluoroscopic view.[17] 
In LAO view RV-A position was demonstrated by a straight or slightly curved anterior lead 
direction (Figure 1).  In RAO fluoroscopic view the RV-A position was confirmed by an 
anterior direction of the leads with the tip electrode close to the inferior part of the sternum. 
This view was also used primarily to avoid lead positioning in RV free wall or in the middle 
or lateral cardiac vein. The RV-A lead position was achieved by using conventional bipolar 
RV pacing leads (n=79) with a stylet. RV-HS lead placement was defined positioning in the 
inferior part of the RVOT in AP fluoroscopy view with a posterior lead tip orientation in 
fluoroscopic LAO view [17] (Figure 2). The RAO fluoroscopic view was used to ensure that 
the RV lead was not positioned in the coronary sinus (CS) or great cardiac vein. For the first  
consecutive 107 patients, the RV-HS lead position was obtained by using the Select Secure 
systemTM (Medtronic, Minneapolis, MN, USA) with deflectable guide catheter. For the next 
49 patients, conventional bipolar RV pacing leads with preshaped stylets were used. 
Table 1. Right Ventricular Bipolar Pacing leads.*
* Medtronic, Minneapolis, MN, USA; RV-A = right ventricular (RV) apical lead position; RV-HS = RV high 
posterior septal lead position.
The first  method to achieve the RV-HS lead position was a catheter  based lead delivery 
system.[18] The deflectable guide catheter was tracked over a guidewire into the RV before 
the guidewire was removed and replaced by the lumenless RV lead. The lead was advanced 
to near the catheter tip and the guide catheter was then deflected and positioned to the inferior 
part  of  RVOT and  to  the  posterior  part  of  interventricular  septum  by  counterclockwise 
rotation of the catheter. After reaching the desired implant site, the lead was advanced to the 
myocardium and fixated by the tip screw, and the deflectable catheter carefully removed. The 
RVOT position was verified by AP view, and posterior pointing verified in LAO view.
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Figure 1. RV-A lead (1;  Medtronic 4076) placement  in fluoroscopic anteroposterior  (AP) and left  anterior  
oblique 30º view (LAO). The coronary venous lead (2; Medtronic 4193) is also shown. RV-A = right ventricular 
apical  lead  placement.                                      
Figure 2.  RV-HS lead (1; Medtronic 4076) placement in flouroscopic anteroposterior (AP) and left anterior  
oblique  30º  view  (LAO).  The  coronary  venous  lead  (2;  Medtronic  4193)  is  also  shown.  RV-HS  =  right 
ventricular  high  posterior  septal  lead  placement.                                 
The second method of obtaining the RV-HS lead position was by using a conventional pacing 
lead manoeuvred by preshaped stylets.[19] First, the lead was advanced to the pulmonary 
artery facilitated by a curved stylet. Next, a second preshaped stylet resembling a swan neck 
was introduced to the lead tip. This stylet had a generous primary curve and a terminal 2cm 
bend to form a secondary curve. The secondary swan neck curve was further modified to 
make the terminal 2cm of the stylet point in a posterior direction. The RV lead was carefully 
pulled back from the pulmonary artery during slight counterclockwise rotation of the stylet to 
facilitate a posterior direction of the lead tip to move to the posterior interventricular septum 
of the RVOT. The position of the lead tip pointing posteriorly was verified in the LAO view 
before the lead was fixed by the tip screw to the myocardial wall.                              
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The CS leads were placed in a lateral or posterolateral CS vein tributary from AP and LAO 
view.20 The right atrial leads were positioned in right appendage demonstrated by an anterior 
and upward position of the distal part of the in the RAO view.[17]                           
Statistical  Analysis                                          
Statistical analyses were performed using SPSS software version 18.0 (SPSS, Chicago, IL).  
All variables are expressed as mean ± SD. Continuous variables were compared by using 
Student  t-test.  Time-related  repeated  measurements  and were  compared  by ANOVA for 
repeated  measurements  with  Greenhouse–Geisser  correction.  Nonparametric  data  were 
analyzed by Pearson χ2  or Fisher's exact test. P-value of < 0.05 was considered statistically 
significant.
Results
Patient  population                                       
Out of 237 patients referred for CRT-P, 158 were selected for RV lead placement in RV-HS 
position. In 2 patients we failed to achieve this lead position (1.3% failure rate), and both 
were  successfully  repositioned  to  RV-A,  and  were  excluded  from  further  analysis. 
Accordingly, the study group consisted of 235 CRT-P patients: 79 patients with RV-A lead 
position and 156 with RV-HS lead position. Baseline characteristics of the study patients are 
listed in Table 2. 
Table 2.  Baseline Characteristics of the Patients According to Right Ventricular Position.
RV-A = right ventricular (RV) apical lead position; RV-HS = RV high posterior septal lead position; NYHA = 
New York Heart Association; LVEF = LV ejection fraction; LVEDD = LV end-diastolic diameter; ACEI = 
angiotensin-converting enzyme inhibitors; ARB = angiotensin receptor blockers.
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Pacing  Thresholds                                        
The average voltage pacing thresholds and pulse duration pacing threshold at 0.5ms and 2.5V 
respectively, in RV-A and RV-HS, are demonstrated in Figure 3 and 4. From implant to 24 
months after CRT, the RV average voltage pacing threshold at  0.5ms remained stable  at 
0.77±0.69V in RV-A (P=0.09) and 0.71±0.35V in RV-HS (P=0.31). From baseline to 24-
month  follow-up,  the  average  RV pulse duration  pacing threshold  at  2.5V was stable  at 
0.06±0.08ms in RV-A (P=0.43) and 0.07±0.05ms in RV-HS (P=0.12). The average pacing 
threshold from CRT implantation to 24 months after CRT were similar between RV-A and 
RV-HS, measured at 0.5ms (p=0.43) and at 2.5V (p=0.12).
Figure 3.  Pacing thresholds at 0.5ms pulse duration measured at baseline and at different follow-up periods 
between RV-A (blue) and RV-HS (green). Abbreviations as in Figure 1 and 2. 
Figure 4.  Pacing thresholds at 2.5V measured at baseline and at different follow-up periods between RV-A 
(blue)  and  RV-HS  (green).  Abbreviations  as  in  Figure  1  and  2.                                    
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Sensing  Electrogram  Amplitudes  and  Lead  Impedances                         
The average sensing electrogram amplitudes and lead impedances from RV-A and RV-HS 
are illustrated in Figure 5 and 6. From implant to 24 months after CRT, the average sensing 
amplitudes  were  stable  at  15.3±6.9mV  in  RV-A  (P=0.55)  and  12.1±6.0mV  in  RV-HS 
(P=0.78), and were comparable between the two RV lead positions (P=0.55). From baseline 
to 24-month follow-up, the lead impedances decreased and averaged at 850±286Ω in RV-A 
(P=0.003) and 618±147Ω in RV-HS (P<0.001), but were not different between the RV-A and 
RV-HS lead position (P=0.57).
Figure 5.  Sensing amplitude threshold measured at baseline and at different follow-up periods between RV-A 
(blue)  and  RV-HS  (green).  Abbreviations  as  in  Figure  1  and  2.                            
Figure 6.  Lead impedances measured at baseline and at different follow-up periods between RV-A (blue) and 
RV-HS  (green).  Abbreviations  as  in  Figure  1  and  2.                                          
Operative  observations                                        
Operative observations are listed in Table 3. The main operative challenges for both RV lead 
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positions  were  either  high  pacing  threshold  or  low  R-wave  amplitudes  that  required 
repositioning of the RV lead. Repositioning procedures of the RV lead was targeted towards 
finding a location as close as possible to the original implant site with acceptable pacing and 
sensing function.  In 8 patients (RV-HS; n=6) it  was difficult  to achieve the anatomically 
appropriate RV lead positions and several lead position attempts were needed to obtain the 
targeted  site.  There  were  4  intraoperative  lead  dislodgements  (RV-HS;  n=3)  that  were 
successfully corrected during the primary operation. No major complications related to RV 
lead  placements  were  observed.                                     
Table 3. Operative Observations.
RV-A = right ventricular (RV) apical lead position; RV-HS = RV high posterior septal lead position.
Late  Lead  Revisions                                                        
Out of the 120 patients with RV-HS lead placement that reached two-year follow-up (lead 
model 3038; n=107; lead model 4076; n=13), RV lead revisions were necessary for 3 patients. 
They all had the lead model 3830. For one patient, lead revision was done after 3 days due to 
loss of pacing capture without lead dislodgement. For the other two patients, revisions were 
completed after 106 days and 491 days, respectively, due to lead dislodgements. Of the 60 
patients with RV-A lead positions that reached two-year follow-up, no RV leads had to be 
revised. The lead revisions performed in the two RV lead positions two years after CRT were 
similar  (P=0.55).                                     
Discussion
The main finding of this 2-year follow-up comparing the electrophysiological performance of 
alternate  RV lead position in CRT-P can  be summarized as  follows:  1)  similar  and stable 
pacing and sensing function in both RV-A and RV-HS during long-term CRT-P; 2) decreasing 
RV lead impedances  during follow-up,  but  comparable findings  between the two RV lead 
positions; 3) similar operative challenges and late RV lead revisions in RV-A and RV-HS.  
To  our  knowledge,  the  current  study  is  the  first  to  compare  the  electrophysiological 
performance of alternate RV lead position in CRT-P. Previous studies have demonstrated the 
pacing lead stability and sensing function in RV-A as compared to alternate RV lead position 
in  bradycardia  indication  for  permanent  pacing.  Burri  et  al  [8]  studied  362  pacemaker 
recipients,  and found similar  pacing-  and sensing lead performance  and need for  RV lead 
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repositioning between RV-A and RVOT. The long-term stability of RV-mid septal position 
was reported by Medi et al [7], in 100 pacemaker patients. The current study demonstrated 
similar long-term electrophysiological performance between RV-A and RV-HS in CRT-P, in 
accordance  with  previous  findings  of  alternate  RV lead  position  in  permanent  pacing  for 
bradycardia. However, the CRT patients with moderate-to-severe heart failure and remodelled 
hearts might be structurally different from the typical population of bradypacing. Moreover, the 
present  study  demonstrates  that  RV-HS  lead  position  is  feasible  also  in  CRT-P  patients,  
including  two  different  methods  for  placement  of  the  RV-HS  lead.                    
RV lead impedances can decrease on long-term follow-up, but might also be dependant on RV 
lead characteristics. [7,8] A decrease in RV-lead impedance was observed in the current study, 
similar  as  the  aforementioned  studies.  Different  RV leads  were  used in  the present  study, 
including 47 of the 79 high-impedance RV-A leads [21], and this might have influenced on the 
electrophysiological  results.  The  reported  complications  to  alternate  RV lead  placement  in 
bradycardia-pacing have been similar as in RV-A. [8] The present study found comparable 
intraoperative  challenges  and  reinterventions  between  the  two  RV  lead  positions.  We 
experienced 3 lead revisions in RV-HS and none in RV-A during two-year follow up, but not 
statistical  significant  different.                                    
Clinical  implications                                       
The current study demonstrates that the RV-HS lead position is feasible in CRT-P. The RV-A 
position in CRT is preferred in CRT, and has demonstrated long-term stability. [4] Moreover, it 
is  essential  that  any alternate positions to the conventional RV-A in CRT maintain similar 
long-term stability. Furthermore, the influence of RV lead position on LV reverse remodelling 
is uncertain, but alternate RV lead position in CRT is feasible as reported in the present study. 
Large prospective randomized trials are needed to identify the optimal RV lead position in 
CRT.
Study  limitations                                     
The  present  retrospective  single-centre  study  may  be  limited  as  the  there  were  no 
randomization of the RV lead positions. Furthermore, the patients were slightly different  at 
baseline as the patients with RV-A lead position suffered from more severe HF. The study 
population might bee too small or the duration of the follow-up period too short to identify 
differences in electrophysiological lead stability or complication rates between the two RV lead 
positions.  Different  RV leads,  including active and passive fixation leads,  were used,  with 
differences in pacing surface area and anode-cathode distance, which can influence the results 
in  this  study.                                                
Conclusion
The present study demonstrate that RV-HS lead position is feasible in CRT-P, with similar 
long-term pacing and sensing functions and associated complications as the conventional RV-
A  lead  placement.                                                
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